Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Gemcitabine
Revenue, means the sales value of Gemcitabine
This report studies sales (consumption) of Gemcitabine in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Allergan
Sanofi
Pfizer
The Medicines Company
Theravance Biopharma
Basilea Pharmaceutica
...
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Gemcitabine in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Gemcitabine in each application, can be divided into
Application 1
Application 2
Application 3
Global Gemcitabine Sales Market Report 2016
1 Gemcitabine Overview
1.1 Product Overview and Scope of Gemcitabine
1.2 Classification of Gemcitabine
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Gemcitabine
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Gemcitabine Market by Regions
1.4.1 United States Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Gemcitabine (2011-2021)
1.5.1 Global Gemcitabine Sales and Growth Rate (2011-2021)
1.5.2 Global Gemcitabine Revenue and Growth Rate (2011-2021)
2 Global Gemcitabine Competition by Manufacturers, Type and Application
2.1 Global Gemcitabine Market Competition by Manufacturers
2.1.1 Global Gemcitabine Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Gemcitabine Revenue and Share by Manufacturers (2011-2016)
2.2 Global Gemcitabine (Volume and Value) by Type
2.2.1 Global Gemcitabine Sales and Market Share by Type (2011-2016)
2.2.2 Global Gemcitabine Revenue and Market Share by Type (2011-2016)
2.3 Global Gemcitabine (Volume and Value) by Regions
2.3.1 Global Gemcitabine Sales and Market Share by Regions (2011-2016)
2.3.2 Global Gemcitabine Revenue and Market Share by Regions (2011-2016)
2.4 Global Gemcitabine (Volume) by Application
3 United States Gemcitabine (Volume, Value and Sales Price)
3.1 United States Gemcitabine Sales and Value (2011-2016)
3.1.1 United States Gemcitabine Sales and Growth Rate (2011-2016)
3.1.2 United States Gemcitabine Revenue and Growth Rate (2011-2016)
3.1.3 United States Gemcitabine Sales Price Trend (2011-2016)
3.2 United States Gemcitabine Sales and Market Share by Manufacturers
3.3 United States Gemcitabine Sales and Market Share by Type
3.4 United States Gemcitabine Sales and Market Share by Application
4 China Gemcitabine (Volume, Value and Sales Price)
4.1 China Gemcitabine Sales and Value (2011-2016)
4.1.1 China Gemcitabine Sales and Growth Rate (2011-2016)
4.1.2 China Gemcitabine Revenue and Growth Rate (2011-2016)
4.1.3 China Gemcitabine Sales Price Trend (2011-2016)
4.2 China Gemcitabine Sales and Market Share by Manufacturers
4.3 China Gemcitabine Sales and Market Share by Type
4.4 China Gemcitabine Sales and Market Share by Application
5 Europe Gemcitabine (Volume, Value and Sales Price)
5.1 Europe Gemcitabine Sales and Value (2011-2016)
5.1.1 Europe Gemcitabine Sales and Growth Rate (2011-2016)
5.1.2 Europe Gemcitabine Revenue and Growth Rate (2011-2016)
5.1.3 Europe Gemcitabine Sales Price Trend (2011-2016)
5.2 Europe Gemcitabine Sales and Market Share by Manufacturers
5.3 Europe Gemcitabine Sales and Market Share by Type
5.4 Europe Gemcitabine Sales and Market Share by Application
6 Japan Gemcitabine (Volume, Value and Sales Price)
6.1 Japan Gemcitabine Sales and Value (2011-2016)
6.1.1 Japan Gemcitabine Sales and Growth Rate (2011-2016)
6.1.2 Japan Gemcitabine Revenue and Growth Rate (2011-2016)
6.1.3 Japan Gemcitabine Sales Price Trend (2011-2016)
6.2 Japan Gemcitabine Sales and Market Share by Manufacturers
6.3 Japan Gemcitabine Sales and Market Share by Type
6.4 Japan Gemcitabine Sales and Market Share by Application
7 Global Gemcitabine Manufacturers Analysis
7.1 Allergan
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Gemcitabine Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Allergan Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
7.1.4 Main Business/Business Overview
7.2 Sanofi
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 102 Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Sanofi Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
7.2.4 Main Business/Business Overview
7.3 Pfizer
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 127 Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Pfizer Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
7.3.4 Main Business/Business Overview
7.4 The Medicines Company
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Nov Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 The Medicines Company Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
7.4.4 Main Business/Business Overview
7.5 Theravance Biopharma
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Theravance Biopharma Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
7.5.4 Main Business/Business Overview
7.6 Basilea Pharmaceutica
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Million USD Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Basilea Pharmaceutica Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
7.6.4 Main Business/Business Overview
...
8 Gemcitabine Maufacturing Cost Analysis
8.1 Gemcitabine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Process Analysis of Gemcitabine
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Gemcitabine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Gemcitabine Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Gemcitabine Market Forecast (2016-2021)
12.1 Global Gemcitabine Sales, Revenue Forecast (2016-2021)
12.2 Global Gemcitabine Sales Forecast by Regions (2016-2021)
12.3 Global Gemcitabine Sales Forecast by Type (2016-2021)
12.4 Global Gemcitabine Sales Forecast by Application (2016-2021)
13 Appendix
Disclosure Section
Research Methodology
Data Source
China Disclaimer
Figure Picture of Gemcitabine
Table Classification of Gemcitabine
Figure Global Sales Market Share of Gemcitabine by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Gemcitabine
Figure Global Sales Market Share of Gemcitabine by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Gemcitabine Revenue and Growth Rate (2011-2021)
Figure China Gemcitabine Revenue and Growth Rate (2011-2021)
Figure Europe Gemcitabine Revenue and Growth Rate (2011-2021)
Figure Japan Gemcitabine Revenue and Growth Rate (2011-2021)
Figure Global Gemcitabine Sales and Growth Rate (2011-2021)
Figure Global Gemcitabine Revenue and Growth Rate (2011-2021)
Table Global Gemcitabine Sales of Key Manufacturers (2011-2016)
Table Global Gemcitabine Sales Share by Manufacturers (2011-2016)
Figure 2015 Gemcitabine Sales Share by Manufacturers
Figure 2016 Gemcitabine Sales Share by Manufacturers
Table Global Gemcitabine Revenue by Manufacturers (2011-2016)
Table Global Gemcitabine Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Gemcitabine Revenue Share by Manufacturers
Table 2016 Global Gemcitabine Revenue Share by Manufacturers
Table Global Gemcitabine Sales and Market Share by Type (2011-2016)
Table Global Gemcitabine Sales Share by Type (2011-2016)
Figure Sales Market Share of Gemcitabine by Type (2011-2016)
Figure Global Gemcitabine Sales Growth Rate by Type (2011-2016)
Table Global Gemcitabine Revenue and Market Share by Type (2011-2016)
Table Global Gemcitabine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Gemcitabine by Type (2011-2016)
Figure Global Gemcitabine Revenue Growth Rate by Type (2011-2016)
Table Global Gemcitabine Sales and Market Share by Regions (2011-2016)
Table Global Gemcitabine Sales Share by Regions (2011-2016)
Figure Sales Market Share of Gemcitabine by Regions (2011-2016)
Figure Global Gemcitabine Sales Growth Rate by Regions (2011-2016)
Table Global Gemcitabine Revenue and Market Share by Regions (2011-2016)
Table Global Gemcitabine Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Gemcitabine by Regions (2011-2016)
Figure Global Gemcitabine Revenue Growth Rate by Regions (2011-2016)
Table Global Gemcitabine Sales and Market Share by Application (2011-2016)
Table Global Gemcitabine Sales Share by Application (2011-2016)
Figure Sales Market Share of Gemcitabine by Application (2011-2016)
Figure Global Gemcitabine Sales Growth Rate by Application (2011-2016)
Figure United States Gemcitabine Sales and Growth Rate (2011-2016)
Figure United States Gemcitabine Revenue and Growth Rate (2011-2016)
Figure United States Gemcitabine Sales Price Trend (2011-2016)
Table United States Gemcitabine Sales by Manufacturers (2011-2016)
Table United States Gemcitabine Market Share by Manufacturers (2011-2016)
Table United States Gemcitabine Sales by Type (2011-2016)
Table United States Gemcitabine Market Share by Type (2011-2016)
Table United States Gemcitabine Sales by Application (2011-2016)
Table United States Gemcitabine Market Share by Application (2011-2016)
Figure China Gemcitabine Sales and Growth Rate (2011-2016)
Figure China Gemcitabine Revenue and Growth Rate (2011-2016)
Figure China Gemcitabine Sales Price Trend (2011-2016)
Table China Gemcitabine Sales by Manufacturers (2011-2016)
Table China Gemcitabine Market Share by Manufacturers (2011-2016)
Table China Gemcitabine Sales by Type (2011-2016)
Table China Gemcitabine Market Share by Type (2011-2016)
Table China Gemcitabine Sales by Application (2011-2016)
Table China Gemcitabine Market Share by Application (2011-2016)
Figure Europe Gemcitabine Sales and Growth Rate (2011-2016)
Figure Europe Gemcitabine Revenue and Growth Rate (2011-2016)
Figure Europe Gemcitabine Sales Price Trend (2011-2016)
Table Europe Gemcitabine Sales by Manufacturers (2011-2016)
Table Europe Gemcitabine Market Share by Manufacturers (2011-2016)
Table Europe Gemcitabine Sales by Type (2011-2016)
Table Europe Gemcitabine Market Share by Type (2011-2016)
Table Europe Gemcitabine Sales by Application (2011-2016)
Table Europe Gemcitabine Market Share by Application (2011-2016)
Figure Japan Gemcitabine Sales and Growth Rate (2011-2016)
Figure Japan Gemcitabine Revenue and Growth Rate (2011-2016)
Figure Japan Gemcitabine Sales Price Trend (2011-2016)
Table Japan Gemcitabine Sales by Manufacturers (2011-2016)
Table Japan Gemcitabine Market Share by Manufacturers (2011-2016)
Table Japan Gemcitabine Sales by Type (2011-2016)
Table Japan Gemcitabine Market Share by Type (2011-2016)
Table Japan Gemcitabine Sales by Application (2011-2016)
Table Japan Gemcitabine Market Share by Application (2011-2016)
Table Allergan Basic Information List
Table Allergan Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Allergan Gemcitabine Global Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Gemcitabine Global Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Gemcitabine Global Market Share (2011-2016)
Table The Medicines Company Basic Information List
Table The Medicines Company Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure The Medicines Company Gemcitabine Global Market Share (2011-2016)
Table Theravance Biopharma Basic Information List
Table Theravance Biopharma Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Theravance Biopharma Gemcitabine Global Market Share (2011-2016)
Table Basilea Pharmaceutica Basic Information List
Table Basilea Pharmaceutica Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Basilea Pharmaceutica Gemcitabine Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gemcitabine
Figure Manufacturing Process Analysis of Gemcitabine
Figure Gemcitabine Industrial Chain Analysis
Table Raw Materials Sources of Gemcitabine Major Manufacturers in 2015
Table Major Buyers of Gemcitabine
Table Distributors/Traders List
Figure Global Gemcitabine Sales and Growth Rate Forecast (2016-2021)
Figure Global Gemcitabine Revenue and Growth Rate Forecast (2016-2021)
Table Global Gemcitabine Sales Forecast by Regions (2016-2021)
Table Global Gemcitabine Sales Forecast by Type (2016-2021)
Table Global Gemcitabine Sales Forecast by Application (2016-2021)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...